| Caffeine | Approved Investigational | CALU | 813 |
downregulated | Caffeine results in decreased expression of CALU mRNA | 7q32.1 | |
| Caffeine | Approved Investigational | CDK4 | 1019 |
downregulated | Caffeine results in decreased expression of CDK4 mRNA | 12q14.1 | |
| Caffeine | Approved Investigational | CREB1 | 1385 |
downregulated | Caffeine results in decreased expression of CREB1 mRNA | 2q33.3 | |
| Caffeine | Approved Investigational | CYC1 | 1537 |
downregulated | Caffeine results in decreased expression of CYC1 mRNA | 8q24.3 | |
| Caffeine | Approved Investigational | CYP4B1 | 1580 |
upregulated | Caffeine results in increased expression of CYP4B1 mRNA | 1p33 | |
| Caffeine | Approved Investigational | DAD1 | 1603 |
downregulated | Caffeine results in decreased expression of DAD1 mRNA | 14q11.2 | |
| Caffeine | Approved Investigational | DCT | 1638 |
upregulated | Caffeine results in increased expression of DCT mRNA | 13q32.1 | |
| Caffeine | Approved Investigational | EIF1 | 10209 |
upregulated | Caffeine results in increased expression of EIF1 mRNA | 17q21.2 | |
| Caffeine | Approved Investigational | GLRX | 2745 |
downregulated | Caffeine results in decreased expression of GLRX mRNA | 5q15 | |
| Caffeine | Approved Investigational | GLT8D1 | 55830 |
downregulated | Caffeine results in decreased expression of GLT8D1 mRNA | 3p21.1 | |
| Caffeine | Approved Investigational | GLUD1 | 2746 |
downregulated | Caffeine results in decreased expression of GLUD1 mRNA | 10q23.2 | |
| Caffeine | Approved Investigational | GSTO1 | 9446 |
downregulated | Caffeine results in decreased expression of GSTO1 mRNA | 10q25.1 | |
| Caffeine | Approved Investigational | HSD11B2 | 3291 |
downregulated | Caffeine results in decreased expression of HSD11B2 mRNA | 16q22.1 | |
| Caffeine | Approved Investigational | IGFBP1 | 3484 |
upregulated | Caffeine results in increased expression of IGFBP1 mRNA | 7p12.3 | |
| Caffeine | Approved Investigational | ITPR1 | 3708 |
downregulated | Caffeine results in decreased expression of ITPR1 mRNA | 3p26.1 | |
| Caffeine | Approved Investigational | LDHA | 3939 |
downregulated | Caffeine results in decreased expression of LDHA mRNA | 11p15.1 | |
| Caffeine | Approved Investigational | LEP | 3952 |
downregulated | Caffeine results in decreased expression of LEP mRNA | 7q32.1 | |
| Caffeine | Approved Investigational | MGST1 | 4257 |
downregulated | Caffeine results in decreased expression of MGST1 mRNA | 12p12.3 | |
| Caffeine | Approved Investigational | MT1G | 4495 |
upregulated | Caffeine results in increased expression of MT1G mRNA | 16q13 | |
| Caffeine | Approved Investigational | OAT | 4942 |
upregulated | Caffeine results in increased expression of OAT mRNA | 10q26.13 | |
| Caffeine | Approved Investigational | PLP1 | 5354 |
upregulated | Caffeine results in increased expression of PLP1 mRNA | Xq22.2 | |
| Caffeine | Approved Investigational | PPP2R2B | 5521 |
downregulated | Caffeine results in decreased expression of PPP2R2B mRNA | 5q32 | |
| Caffeine | Approved Investigational | PRELID1 | 27166 |
downregulated | Caffeine results in decreased expression of PRELID1 mRNA | 5q35.3 | |
| Caffeine | Approved Investigational | PRNP | 5621 |
downregulated | Caffeine results in decreased expression of PRNP mRNA | 20p13 | |
| Caffeine | Approved Investigational | PSME3 | 10197 |
downregulated | Caffeine results in decreased expression of PSME3 mRNA | 17q21.31 | |